Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Payables (2020 - 2025)

Historic Payables for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $5.5 million.

  • iSpecimen's Payables fell 764.42% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 764.42%. This contributed to the annual value of $4.2 million for FY2024, which is 693.23% up from last year.
  • Per iSpecimen's latest filing, its Payables stood at $5.5 million for Q3 2025, which was down 764.42% from $5.0 million recorded in Q2 2025.
  • iSpecimen's Payables' 5-year high stood at $5.9 million during Q3 2024, with a 5-year trough of $832678.0 in Q4 2021.
  • For the 5-year period, iSpecimen's Payables averaged around $3.6 million, with its median value being $3.8 million (2023).
  • Data for iSpecimen's Payables shows a peak YoY increase of 19531.98% (in 2022) and a maximum YoY decrease of 6999.93% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows iSpecimen's Payables stood at $832678.0 in 2021, then skyrocketed by 195.32% to $2.5 million in 2022, then skyrocketed by 59.63% to $3.9 million in 2023, then rose by 6.93% to $4.2 million in 2024, then skyrocketed by 30.74% to $5.5 million in 2025.
  • Its last three reported values are $5.5 million in Q3 2025, $5.0 million for Q2 2025, and $4.6 million during Q1 2025.